- Home
- IVA vs KOS Comparison
IVA vs KOS Comparison
Compare IVA & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- KOS
- Stock Information
- Founded
- IVA 2011
- KOS 2003
- Country
- IVA France
- KOS United States
- Employees
- IVA N/A
- KOS N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- KOS Oil & Gas Production
- Sector
- IVA Health Care
- KOS Energy
- Exchange
- IVA Nasdaq
- KOS Nasdaq
- Market Cap
- IVA 769.0M
- KOS 870.4M
- IPO Year
- IVA 2020
- KOS 2011
- Fundamental
- Price
- IVA $5.61
- KOS $1.67
- Analyst Decision
- IVA Strong Buy
- KOS Buy
- Analyst Count
- IVA 6
- KOS 6
- Target Price
- IVA $15.33
- KOS $4.52
- AVG Volume (30 Days)
- IVA 74.4K
- KOS 7.8M
- Earning Date
- IVA 09-26-2025
- KOS 11-03-2025
- Dividend Yield
- IVA N/A
- KOS N/A
- EPS Growth
- IVA N/A
- KOS N/A
- EPS
- IVA N/A
- KOS N/A
- Revenue
- IVA $14,591,573.00
- KOS $1,488,836,000.00
- Revenue This Year
- IVA $80.35
- KOS N/A
- Revenue Next Year
- IVA N/A
- KOS $12.29
- P/E Ratio
- IVA N/A
- KOS N/A
- Revenue Growth
- IVA N/A
- KOS N/A
- 52 Week Low
- IVA $1.53
- KOS $1.39
- 52 Week High
- IVA $6.50
- KOS $4.69
- Technical
- Relative Strength Index (RSI)
- IVA 60.84
- KOS 42.58
- Support Level
- IVA $5.21
- KOS $1.64
- Resistance Level
- IVA $5.78
- KOS $1.77
- Average True Range (ATR)
- IVA 0.38
- KOS 0.09
- MACD
- IVA -0.02
- KOS 0.00
- Stochastic Oscillator
- IVA 54.82
- KOS 19.64
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.